Please use this identifier to cite or link to this item:
Title: Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Authors: Mei, L.
Zhang, Z.
Zhao, L.
Huang, L.
Yang, X.-L.
Tang, J.
Feng, S.-S. 
Keywords: Bioavailability
Biodegradable polymers
Cancer nanotechnology
Chemotherapeutic engineering
Gastrointestinal barrier (GI barrier)
Issue Date: 15-Jun-2013
Citation: Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., Feng, S.-S. (2013-06-15). Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Advanced Drug Delivery Reviews 65 (6) : 880-890. ScholarBank@NUS Repository.
Abstract: Oral chemotherapy is an important topic in the 21st century medicine, which may radically change the current regimen of chemotherapy and greatly improve the quality of life of the patients. Unfortunately, most anticancer drugs, especially those of high therapeutic efficacy such as paclitaxel and docetaxel, are not orally bioavailable due to the gastrointestinal (GI) drug barrier. The molecular basis of the GI barrier has been found mainly due to the multidrug efflux proteins, i.e. P-type glycoproteins (P-gp), which are rich in the epithelial cell membranes in the GI tract. Medical solution for oral chemotherapy is to apply P-gp inhibitors such as cyclosporine A, which, however, suppress the body's immune system either, thus causing medical complication. Pharmaceutical nanotechnology, which is to apply and further develop nanotechnology to solve the problems in drug delivery, may provide a better solution and thus change the way we make drug and the way we take drug. This review is focused on the problems encountered in oral chemotherapy and the pharmaceutical nanotechnology solutions such as prodrugs, nanoemulsions, dendrimers, micelles, liposomes, solid lipid nanoparticles and nanoparticles of biodegradable polymers. Proof-of-concept in vitro and in vivo results for oral delivery of anticancer drugs by the various nanocarriers, which can be found so far from the literature, are provided. © 2012 Elsevier B.V.
Source Title: Advanced Drug Delivery Reviews
ISSN: 0169409X
DOI: 10.1016/j.addr.2012.11.005
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Sep 21, 2018


checked on Sep 11, 2018

Page view(s)

checked on Sep 21, 2018

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.